tDCS + Speech-Language Therapy for Aphasia
(AphasiatDCS Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new approach to assist people with aphasia (difficulty with speech and language) after a stroke. It combines a technique called tDCS (Transcranial Direct Current Stimulation), which gently stimulates the brain electrically, with speech-language therapy. Participants will receive either the actual tDCS treatment or a placebo version, alongside the therapy sessions. It suits those who had a stroke over a year ago and continue to experience speech difficulties. The goal is to determine if this combined treatment can enhance speech and language skills. As an unphased trial, this study provides a unique opportunity to explore innovative treatments for improving these skills.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this tDCS + Speech-Language Therapy is safe for treating aphasia?
Research shows that transcranial Direct Current Stimulation (tDCS) is generally safe for people recovering from strokes. tDCS is a noninvasive and painless method that uses a small electrical current to stimulate the brain. People with aphasia, a condition affecting speaking and understanding language, have used tDCS in their recovery without major problems.
Studies report that tDCS is well-tolerated. The most common side effects are mild and temporary, such as a tingling sensation or slight skin irritation where the stimulation is applied. These effects usually disappear quickly. One study found that using tDCS along with speech therapy is effective and safe in the early stages of aphasia recovery.
For those considering joining a trial involving tDCS, research suggests the treatment is safe with minimal side effects.12345Why are researchers excited about this trial?
Researchers are excited about the use of targeted transcranial direct current stimulation (tDCS) for treating aphasia because it offers a non-invasive approach that may enhance brain plasticity and recovery post-stroke. Unlike traditional speech-language therapy alone, which primarily relies on repetitive practice to improve language skills, tDCS involves a gentle electrical current that can stimulate specific brain areas, potentially speeding up the recovery process. This combination of tDCS with speech-language training could lead to more effective and quicker improvements in language function, making it a promising option for those affected by stroke-induced aphasia.
What evidence suggests that this trial's treatments could be effective for aphasia?
Research shows that a gentle electrical brain stimulation technique called transcranial direct current stimulation (tDCS), combined with speech-language therapy (SLT), might help people with aphasia recover language skills after a stroke. In this trial, participants will be divided into two groups: one will receive active cathodal tDCS with speech-language training, while the other will receive placebo cathodal tDCS with speech-language training. Studies have found that tDCS can improve speech content and the ability to name objects. Some reviews and analyses also suggest it may help with general language skills, such as repeating words and speaking smoothly. However, results are mixed, and not all studies have found tDCS more effective than other treatments. The potential for tDCS to aid language recovery continues to be actively explored.23678
Who Is on the Research Team?
Jessica Richardson, Ph.D.
Principal Investigator
University of New Mexico
Are You a Good Fit for This Trial?
This trial is for individuals aged 25-85 who are more than a year post-stroke and have aphasia, which affects their language abilities. They must show left-hemisphere brain damage and be responsive to naming tasks. People with other neurological diseases, right hemisphere damage, mood disorders, recent substance abuse, electrical implants that interfere with tDCS or MRI scans, medical instability or pregnancy cannot participate.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo 15 sessions of tDCS combined with speech-language training on consecutive weekdays
Assessment
Participants have 4 assessment sessions: 2 pretreatment, 1 immediately post-treatment, and 1 at 3 months follow-up
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Targeted TDCS
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of New Mexico
Lead Sponsor
National Institute on Deafness and Other Communication Disorders (NIDCD)
Collaborator
National Institutes of Health (NIH)
Collaborator
National Institute of General Medical Sciences (NIGMS)
Collaborator